References
- Burgess C. D., McKee C. E. L., Wilson C. A., Warren D. J. The effect of indapamide on muscle blood flow in hypertensive patients. Postgrad. Med. J. 1981; 57(Suppl. 2)23–25
- Campbell D. B., Moore R. A. The pharmacology and clinical pharmacology of indapamide. Postgrad. Med. J. 1981; 57(Suppl. 2)7–17
- De Champlain J., Farley L., Cousineau D., Van Ameringen M. R. Circulating catecholamine levels in human and experimental hypertension. Circ. Res. 1976; 38: 109–114
- Demanet J. C., Degaute J. P., Hubert C. Safety and therapeutic efficacy in a long-term study of indapamide in the treatment of essential hypertension. Curr: Med. Res. Opin. 1977; 5(Suppl. 1)129–136
- Grimm M., Weidmann P., Meier A., Keusch C., Ziegler W., Cluck Z., Beretta-Piccoli C. Correction of altered noradrenaline reactivity in essential hypertension by indapamide. Br. Heart J. 1981; 46: 404–409
- Isaac R., Witchitz S., Kamoun A., Bagattini J. C. A long-term study of the influences of indapamide on the exchangeable potassium and sodium pools in hypertensive patients. Curr. Med. Res. Opin. 1977; 5(Suppl. 1)64–70
- Johnson L. A., Baker C. A., Smith R. T. Radioenzymatic assay of sulfate conjugates of catecholamines and dopa. Plasma 1980; 26: 1591–1598
- Kubik M. M., Coote J. H. Comparison of the antihypertensive effects of indapamide and metoprolol. Postgrad. Med. J. 1981; 57(Suppl. 2)44–50
- Lake C. R., Ziegler M. G., Coleman M. D., Kopin I. J. Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N. Engl. J. Med. 1977; 296: 208–209
- Leenen F. H, H., Smith D. L., Boer W. H., Marquez-Julio A. Diuretic and cardiovascular effects of indapamide in hypertensive subjects: a dose-response curve. Curr: Med. Res. Opin. 1983; 8(Suppl. 3)47–52
- Mimran A., Zambrowski J. J., Coppolani T. The antihypertensive action of indapamide: results of a French multi-centre study of 2184 ambulant patients. Postgrad. Med. J. 1981; 57(Suppl. 2)60–63
- Passeron J., Pauly N., Desprat J. International multi-centre study of indapamide in the treatment of essential arterial hypertension. Postgrad. Med. J. 1981; 57(Suppl. 2)57–59
- Passon P. G., Peuler J. D. A simplified radiometric assay for plasma norepinephrine and epinephrine. Anal. Biochem. 1973; 51: 619–631
- Pedersen E. B., Christensen N. J. Catecholamines in plasma and urine in patients with essential hypertension determined by double isotope derivation techniques. Acta Med. Scand. 1975; 198: 373–377
- Schlesinger P., Oignam W., Tabet F. F., Benchimol A. B. The treatment of hypertension with indapamide: a controlled trial. Curr. Med. Res. Opin. 1977; 5(Suppl. 1)159–164
- Weidmann P., Keusch C., Meier A., Cluck Z., Grimm M., Beretta-Piccoli C. Effects of indapamide on the body sodium-volume state, plasma, renin, aldosterone and catecholamines and cardiovascular pressor sensitivity in normal and borderline hypertensive man. “Proceedings of the Second International Symposium on Arterial Hypertension”, M. Velasco. Excerpta Medica, Amsterdam 1980; 169, Int. Congr. Series No. 496.
- Zacharias F. J. A comparative study of the efficacy of indapamide and bendrofluazide given in combination with atenolol. Postgrad. Med. J. 1981; 57(Suppl. 2)51–52